Alpha Teknova, Inc. (TKNO): Total Assets
$103.58M
As of 2025-12-31
$95.88M
As of 2026-06-30
-12.1%
3-year compound annual growth
+10.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $103.58M | -12.8% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $118.77M | -7.6% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $128.59M | -15.5% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $152.26M | -8.6% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $166.51M | +164.7% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $62.91M | n/a | 2022-03-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $842.13M | -29.3% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.46M | -0.6% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.24M | +59.8% |
| Biomerica Inc (BMRA) | 2026-05-31 | $6.76M | +13.7% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $25.76M | -26.6% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $706.60M | -31.2% |
| Neogen Corp (NEOG) | 2026-05-31 | $3.35B | -2.8% |
Compare TKNO, ICCC, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗